MLchartDataset catalogue

MET tyrosine kinase inhibitor EMD 1204831

Term · Oncology and biomedicine · MLC-T-ONC-015111

An inhibitor of the receptor tyrosine kinase MET (hepatocyte growth factor receptor) with potential antineoplastic activity. MET inhibitor EMD 1204831 selectively binds to MET tyrosine kinase, thereby disrupting MET-mediated signal transduction pathways. This may induce cell death in tumor cells overexpressing this kinase. MET is overexpressed or mutated in many tumor cell types, and plays key roles in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis.

Table 1. Record
IdentifierMLC-T-ONC-015111
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015111",
  "term": "MET tyrosine kinase inhibitor EMD 1204831",
  "field": "Oncology and biomedicine",
  "definition": "An inhibitor of the receptor tyrosine kinase MET (hepatocyte growth factor receptor) with potential antineoplastic activity. MET inhibitor EMD 1204831 selectively binds to MET tyrosine kinase, thereby disrupting MET-mediated signal transduction pathways. This may induce cell death in tumor cells overexpressing this kinase. MET is overexpressed or mutated in many tumor cell types, and plays key roles in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/met-tyrosine-kinase-inhibitor-emd-1204831/"
}

Record 10,891 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.